Condition (MeSH)
Vascular Headaches
ClinicalTrials.gov lists 5 trials for Vascular Headaches or a narrower condition beneath it. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Vascular Headaches itself; the rest are tagged with a narrower condition beneath it.
When did Vascular Headaches trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2014 | 1 |
| 2005 | 1 |
| 2000 | 1 |
| 1999 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Vascular Headaches trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
| Not applicable | 1 |
How many Vascular Headaches trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 4 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Vascular Headaches trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| US Department of Veterans Affairs | 1 |
| VA Office of Research and Development | 1 |
Which publications cover Vascular Headaches? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes. | Emergency medicine journal : EMJ | 2004 | Yes |
| The role of nitric oxide in vascular headache. | Pharmacy world & science : PWS | 2003 | Yes |
| Cocaine as an abortive agent in cluster headache. | Headache | 1982 | Yes |
| Studies on headache; evidence of damage and changes in pain sensitivity in subjects with vascular headaches of the migraine type. | A.M.A. archives of internal medicine | 1953 | Yes |
| Occipital neuralgia. | Clinical and experimental neurology | 1978 | No |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.